Joseph Michael Fitzgerald Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 month, 2 weeks ago
Joseph Michael Fitzgerald has an estimated net worth of at least $75.6 million*, as of Oct. 29, 2025. They own 173,276 shares of BSX stock. They have sold 810,611 shares of BSX stock since 2021, for an estimated $57.2 million.
Joseph Michael Fitzgerald $BSX SEC Form 4 Insider Trading
Joseph Michael Fitzgerald has filed a total of 20 insider trades in $BSX since 2021. Their most recent trade was a sale of 29,472 shares, made on Nov 03, 2025. Their largest trade was a sale of 132,527 shares, made on Oct 07, 2024. We estimate that they now own 173,276 shares of $BSX, worth an estimated $18.4 million.
Insider Trading at $BSX
There have been a total of 201 insider trades reported at $BSX since 2021, with 25,050 shares purchased and 5.4 million shares sold. The most active insider traders in $BSX stock have been Wendy Carruthers, Jeffrey B. Mirviss, and Michael F Mahoney. The most recent trade was a sale of 17,313 shares reported by Arthur C Butcher (EVP& Grp Pres, MedSurg & APAC), made on Dec 01, 2025.
History of Insider Stock Trades by Joseph Michael Fitzgerald
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
BSX
|
Sale | 29,472 | Nov 03, 2025 | Nov. 4, 2025, 5:15 p.m. |
|
BSX
|
Sale | 3,600 | Nov 03, 2025 | Nov. 4, 2025, 5:15 p.m. |
|
BSX
|
Sale | 16,928 | Nov 03, 2025 | Nov. 4, 2025, 5:15 p.m. |
|
BSX
|
Sale | 41,755 | Oct 01, 2025 | Oct. 1, 2025, 4:22 p.m. |
|
BSX
|
Sale | 8,245 | Oct 01, 2025 | Oct. 1, 2025, 4:22 p.m. |
|
BSX
|
Sale | 21,830 | Sep 02, 2025 | Sept. 3, 2025, 4:17 p.m. |
|
BSX
|
Sale | 28,170 | Sep 02, 2025 | Sept. 3, 2025, 4:17 p.m. |
|
BSX
|
Sale | 50,000 | Aug 01, 2025 | Aug. 4, 2025, 5:43 p.m. |
|
BSX
|
Sale | 50,000 | Jul 01, 2025 | July 2, 2025, 4:09 p.m. |
|
BSX
|
Sale | 56,372 | Jun 04, 2025 | June 4, 2025, 7:44 p.m. |
|
BSX
|
Purchase | 50 | Dec 03, 2024 | Feb. 13, 2025, 5:32 p.m. |
|
BSX
|
Sale | 20 | Dec 10, 2024 | Feb. 13, 2025, 5:32 p.m. |
|
BSX
|
Sale | 132,527 | Oct 07, 2024 | Oct. 8, 2024, 5:48 p.m. |
|
BSX
|
Sale | 14,132 | Aug 28, 2024 | Aug. 29, 2024, 4:13 p.m. |
|
BSX
|
Sale | 11,660 | Jan 12, 2024 | Jan. 16, 2024, 5:39 p.m. |
|
BSX
|
Sale | 81,940 | Dec 29, 2023 | Jan. 2, 2024, 9:30 p.m. |
|
BSX
|
Sale | 15,867 | Sep 20, 2023 | Sept. 21, 2023, 4:09 p.m. |
|
BSX
|
Sale | 63,339 | May 16, 2023 | May 17, 2023, 4:30 p.m. |
|
BSX
|
Sale | 79,264 | Dec 13, 2022 | Dec. 14, 2022, 5:37 p.m. |
|
BSX
|
Sale | 105,490 | Jul 27, 2021 | July 26, 2021, 8 p.m. |
$BSX Executives and Stock Owners with Insider Trades
-
Wendy Carruthers, EVP, Human Resources
-
Jeffrey B. Mirviss, EVP&Pres, Periph Intervent
-
Michael F Mahoney, Chairman, President & CEO
-
Joseph Michael Fitzgerald, EVP & Group Pres, Cardiology
-
Arthur C Butcher, EVP& Grp Pres, MedSurg & APAC
-
Daniel J. Brennan, EVP and CFO
-
John Bradley Sorenson, EVP, Global Operations
-
Vance R Brown, SVP, GC and Corp. Secretary
-
Wendy Carruthers, SVP, Human Resources
-
David A Pierce, EVP Pres MedSurg
-
Jodi Euerle Eddy, SVP, Chief Info & Digital Off.
-
Eric Francis Yves Thepaut, EVP & Pres, Eur, Mid-East, Afr
-
Jonathan Monson, VP, Global Controller and CAO
-
Arthur C Butcher, EVP&Pres, Asia Pacific
-
Meghan Scanlon, SVP,Pres,Urology Pelvic Health
-
Emily Woodworth, SVP, Global Controller and CAO
-
Scott Olson, SVP & Pres, CRM, Diagnostics
-
Scott Olson, SVP & Pres, Rhythm Management
-
Jonathan Monson, SVP, Global Controller and CAO
-
Ian T Meredith, EVP Global Chief Med Officer
-
John Bradley Sorenson, SVP, Global Supply Chain
-
Joseph Michael Fitzgerald, EVP & Pres, Interven Cardio
-
Maulik Nanavaty, SVP & Pres, Neuromodulation
-
Edward F Mackey, EVP, Operations
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.